MAPK2

MAPK2 (PF3D7_1113900/Pfmap-2) is an atypical MAP kinase-family enzyme of Plasmodium falciparum that functions in stage-specific signaling, most critically during sexual development (PMID:10514473, PMID:32681115). It is a catalytically active kinase that autophosphorylates and phosphorylates myelin basic protein, and its activity is reversed by a MAPK-specific phosphatase; unusually, it lacks the canonical threonine-X-tyrosine activation motif and instead carries a threonine-serine-histidine (TSH) motif at the equivalent position (PMID:10514473). Its activation state is set by upstream NIMA-related kinases: Pfnek-1 and Pfnek3 each directly phosphorylate and stimulate MAPK2 in vitro, with Pfnek3 acting specifically on MAPK2 and not on Pfmap-1 or human MAPK1 (PMID:11322879, PMID:17064692). Conditional excision established that MAPK2 is dispensable for asexual proliferation, sexual commitment, and gametocytogenesis, but is required for male gametogenesis — specifically to initiate axonemal beating, while DNA replication and axoneme assembly proceed normally in its absence (PMID:32681115). The narrative of essentiality diverges by approach: earlier gene-disruption attempts in P. falciparum implied MAPK2 was required for the asexual cycle and pointed to a compensatory relationship with Pfmap-1 (PMID:17651389), whereas conditional-excision and double-null analysis showed no asexual defect (PMID:32681115).

1. 1999 High

   Establishing whether Pfmap-2 encodes a genuine kinase and how it relates to canonical MAPKs was the first requirement; the study showed it is an active, regulatable kinase but with a divergent activation motif, defining it as an atypical MAPK.

   Evidence Recombinant expression in E. coli with in vitro autophosphorylation and MBP kinase assays, phosphatase treatment, and active-site mutagenesis

   PMID:10514473

   Open questions at the time

   • The physiological substrate(s) beyond MBP were not identified
   • The functional significance of the TSH-versus-TXY motif for regulation was not resolved
2. 1999 Medium

   Whether MAPK2 acts constitutively or in a stage-restricted manner was addressed by showing gametocyte-specific expression and preferential activation by gametocyte extracts, pointing toward a role in transmission stages.

   Evidence Northern blot, immunofluorescence, and in vitro activation with stage-specific parasite extracts

   PMID:10514473

   Open questions at the time

   • The activating component in gametocyte extracts was not identified
   • Stage-specific expression alone did not establish a gametocyte function
3. 2001 Medium

   The question of what regulates MAPK2 upstream was first answered by identifying Pfnek-1 as a NIMA-related kinase that phosphorylates MAPK2 and synergizes with it on substrate, placing a Nek kinase upstream of the MAPK2 pathway.

   Evidence In vitro kinase and substrate-labelling assays with recombinant Pfnek-1 and MAPK2

   PMID:11322879

   Open questions at the time

   • Interaction shown only in vitro with recombinant proteins
   • Whether Pfnek-1 activates MAPK2 in the parasite was not tested
4. 2006 Medium

   Extending upstream regulation, Pfnek3 was shown to phosphorylate and stimulate MAPK2 specifically — not Pfmap-1 or human MAPK1 — establishing a dedicated Nek3-MAPK2 regulatory link.

   Evidence In vitro phosphorylation/stimulation assay with recombinant proteins and specificity controls

   PMID:17064692

   Open questions at the time

   • Specificity demonstrated in vitro only
   • In vivo requirement for Pfnek3 in MAPK2 activation not established
5. 2007 Medium

   The requirement of MAPK2 for the asexual cycle was probed by reverse genetics; failed disruption in P. falciparum implied essentiality and revealed compensatory upregulation in pfmap-1 knockouts, while the P. berghei ortholog was dispensable — an early sign of species/approach divergence.

   Evidence Gene-disruption attempts and western blot of protein levels in knockout lines

   PMID:17651389

   Open questions at the time

   • Failed disruption is indirect evidence of essentiality and was later contradicted by conditional excision
   • Mechanism of Pfmap-1/MAPK2 compensation not defined
6. 2016 Low

   Where MAPK2 acts within the asexual parasite was addressed by localizing both phospho- and non-phospho forms to the nucleus, with expression peaking at the ring/early trophozoite stage.

   Evidence Immunofluorescence, immunoelectron microscopy, and western blot with a TSH-motif-specific antibody

   PMID:27525262

   Open questions at the time

   • Localization established with no direct functional consequence
   • Nuclear substrates and the role of the phosphorylated form were not identified
7. 2020 High

   Conditional excision resolved the essentiality question and pinpointed the true function: MAPK2 is dispensable for asexual growth and gametocytogenesis but required to initiate axonemal beating during male gametogenesis, with axoneme formation and DNA replication intact.

   Evidence DiCre conditional excision with gametogenesis phenotyping (DNA replication, axoneme formation, flagellar motility) and PfMAP-2/PfMAP-1 double-null analysis

   PMID:32681115

   Open questions at the time

   • The molecular targets of MAPK2 that trigger axonemal beating are unknown
   • How MAPK2 couples to the motility machinery was not defined
8. 2025 Low

   Placing MAPK2 in a broader signaling context, transcriptomics of a PbPP6 knockout showed strong downregulation of nek3, positioning MAPK2 downstream of PKG-Ca2+ signaling during male gametogenesis.

   Evidence Transcriptomic analysis of pbpp6 knockout P. berghei

   PMID:40623036

   Open questions at the time

   • Pathway placement inferred from a different gene's knockout with no direct MAPK2 experiment
   • Direct connection between PKG-Ca2+ signaling and MAPK2 activation not tested

• The physiological substrates of MAPK2 and the mechanism by which it triggers axonemal beating downstream of PKG-Ca2+ signaling remain undefined.
• No in vivo substrate identified beyond the in vitro MBP model
• Mechanistic link between MAPK2 activity and flagellar motility unknown
• In vivo relevance of Nek1/Nek3-mediated activation not established